or Try an Advanced Search...

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    LLY B Eli Lilly and Company -0.15
    NSPR D InspireMD, Inc. 0.00
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 23.17
    MEDX C Horizon Kinetics Medical ETF 15.83
    PPH A Market Vectors Pharmaceutical ETF 11.96
    IYH B iShares U.S. Healthcare ETF 11.86
    XLV B SPDR Select Sector Fund - Health Care 11.67
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to IYH Compare MEDX to IYH Compare MEDX to XLV

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        May 17 LLY Top Research Reports for Microsoft, Eli Lilly & Costco
        May 17 LLY 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 LLY Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
        May 17 LLY Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
        May 17 LLY Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
        May 17 LLY Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
        May 17 LLY Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs
        May 16 LLY 3 Stocks to Buy Following Positive Earnings Results
        May 16 LLY 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
        May 16 LLY Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
        May 16 LLY Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
        May 16 LLY Lilly’s once-weekly insulin matches daily shots in late-stage tests
        May 16 LLY Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
        May 16 LLY Eli Lilly once-weekly insulin hits main goal in late-stage trials
        May 16 LLY These 2 No-Brainer Growth Stocks Are Breaking New Ground
        May 16 LLY UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
        May 16 LLY With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
        May 15 LLY Dow Jones Futures: Dow, S&P 500, Nasdaq Hit Highs, Nvidia Leads 12 New Buys; What To Do Now
        May 15 LLY Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 LLY Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags